Rome, Nov 10. (Adnkronos Health) – “Nasal polyposis is a very common disease, present in 4% of the population. What makes it even more complex is the fact that in 60-70% of cases there is respiratory comorbidity. Hence the need to address the pathology with a multidisciplinary and multi-organ approach.” This was stated by Michele Barbara, president of Sioechcf – Italian Society of Otorhinolaryngology and Head and Neck Surgery, participating in the meeting ‘Respiratory health in Italy and therapeutic innovation. Towards a shared roadmap for severe asthma, COPD and nasal polyposis’, today, in Rome.
“The upper respiratory tracts are connected to the lower ones not only from a morphological and anatomical point of view but also functionally, especially from an immunological aspect – clarifies the expert – To see results in patients, frequent and continuous monitoring is necessary. Telemedicine and artificial intelligence can help us both to follow the patient and to connect markers preventively, prospectively, to know the outcome of disease resolution. I hope that research continues, because it helps people live better. Costs must not represent a limit, when we talk about quality of life, personalized therapy, we talk about people. The disease belongs to the person,” he concludes.